Time
14:20
Sonnet BioTherapeutics receives shareholder approval for a business merger with Hyperliquid Strategies, Inc.
December 2, 2025
CoinFeed News
Nasdaq-listed biotechnology company Sonnet BioTherapeutics has received shareholder approval for a business merger with Hyperliquid Strategies, Inc.